BFC Planning’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$567 Hold
8
– – ﹤0.01% 3274
2026
Q2
$568 Hold
8
– – ﹤0.01% 3236
2026
Q1
$541 Hold
8
– – ﹤0.01% 2844
2025
Q4
$332 Buy
+8
New +$331 ﹤0.01% 2988

Other funds holding CGON

BFC Planning's CGON Position: Q3 2026 in Review

BFC Planning held its CG Oncology (CGON) position steady in Q3 2026 at 8 shares worth $567. The position accounts for ﹤0.01% of the portfolio, ranked #3274.

BFC Planning first reported a position in CGON in Q4 2025 and has held it in 4 quarters since. The position peaked at $568 in Q2 2026. 165 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • BFC Planning held 8 shares of CG Oncology worth $567 as of Q3 2026.
  • BFC Planning left its CG Oncology share count unchanged in Q3 2026.
  • CG Oncology made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3274 holding.
  • BFC Planning first reported a position in CG Oncology in Q4 2025 and has held it in 4 quarters since.
  • BFC Planning's CG Oncology position peaked at $568 in Q2 2026.
  • 165 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.